🇺🇸 FDA
Patent

US 11912762

Method of treating osteoarthritis by administering an anti-connexin 43 antibody

granted A61KA61K49/0008A61P

Quick answer

US patent 11912762 (Method of treating osteoarthritis by administering an anti-connexin 43 antibody) held by The Board of Regents of the University of Texas System expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K49/0008, A61P, A61P19/02